CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents Syncope After Percutaneous Coronary Intervention The year in cardiovascular medicine 2020: interventional cardiology Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study) Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis

Guideline31 August 2019

JOURNAL:Eur Heart J. Article Link

2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)he management of patients with)

J Brugada, DG Katritsis, ESC Scientific Document Group et al. Keywords: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz467/5556821

FULL TEXT PDF